Tuning levels of low-complexity domain interactions to modulate endogenous oncogenic transcription
- PMID: 35483357
- DOI: 10.1016/j.molcel.2022.04.007
Tuning levels of low-complexity domain interactions to modulate endogenous oncogenic transcription
Abstract
Gene activation by mammalian transcription factors (TFs) requires multivalent interactions of their low-complexity domains (LCDs), but how such interactions regulate transcription remains unclear. It has been proposed that extensive LCD-LCD interactions culminating in liquid-liquid phase separation (LLPS) of TFs is the dominant mechanism underlying transactivation. Here, we investigated how tuning the amount and localization of LCD-LCD interactions in vivo affects transcription of endogenous human genes. Quantitative single-cell and single-molecule imaging reveals that the oncogenic TF EWS::FLI1 requires a narrow optimum of LCD-LCD interactions to activate its target genes associated with GGAA microsatellites. Increasing LCD-LCD interactions toward putative LLPS represses transcription of these genes in patient-derived cells. Likewise, ectopically creating LCD-LCD interactions to sequester EWS::FLI1 into a well-documented LLPS compartment, the nucleolus, inhibits EWS::FLI1-driven transcription and oncogenic transformation. Our findings show how altering the balance of LCD-LCD interactions can influence transcriptional regulation and suggest a potential therapeutic strategy for targeting disease-causing TFs.
Keywords: EWS::FLI1; Ewing sarcoma; intrinsically disordered regions; liquid-liquid phase separation; low-complexity domains; multivalent interactions; nucleolus; single-cell and single-molecule imaging; transcription factor; transcriptional control.
Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests R. Tjian and X. Darzacq are co-founders of Eikon Therapeutics.
Comment in
-
Regulating gene expression through control of transcription factor multivalent interactions.Mol Cell. 2022 Jun 2;82(11):1974-1975. doi: 10.1016/j.molcel.2022.05.015. Mol Cell. 2022. PMID: 35659322
Similar articles
-
EWS-FLI1 regulates a transcriptional program in cooperation with Foxq1 in mouse Ewing sarcoma.Cancer Sci. 2018 Sep;109(9):2907-2918. doi: 10.1111/cas.13710. Epub 2018 Jul 18. Cancer Sci. 2018. PMID: 29945296 Free PMC article.
-
BET bromodomain inhibitors suppress EWS-FLI1-dependent transcription and the IGF1 autocrine mechanism in Ewing sarcoma.Oncotarget. 2016 Jul 12;7(28):43504-43517. doi: 10.18632/oncotarget.9762. Oncotarget. 2016. PMID: 27259270 Free PMC article.
-
The oncogenic EWS-FLI1 protein binds in vivo GGAA microsatellite sequences with potential transcriptional activation function.PLoS One. 2009;4(3):e4932. doi: 10.1371/journal.pone.0004932. Epub 2009 Mar 23. PLoS One. 2009. PMID: 19305498 Free PMC article.
-
Oncogenic partnerships: EWS-FLI1 protein interactions initiate key pathways of Ewing's sarcoma.Clin Cancer Res. 2010 Aug 15;16(16):4077-83. doi: 10.1158/1078-0432.CCR-09-2261. Epub 2010 Jun 14. Clin Cancer Res. 2010. PMID: 20547696 Free PMC article. Review.
-
Blocking the road, stopping the engine or killing the driver? Advances in targeting EWS/FLI-1 fusion in Ewing sarcoma as novel therapy.Expert Opin Ther Targets. 2014 Nov;18(11):1315-28. doi: 10.1517/14728222.2014.947963. Epub 2014 Aug 27. Expert Opin Ther Targets. 2014. PMID: 25162919 Review.
Cited by
-
Dysregulation of transcriptional condensates in human disease: mechanisms, biological functions, and open questions.Curr Opin Genet Dev. 2024 Jun;86:102203. doi: 10.1016/j.gde.2024.102203. Epub 2024 May 23. Curr Opin Genet Dev. 2024. PMID: 38788489 Review.
-
Transcription regulation by biomolecular condensates.Nat Rev Mol Cell Biol. 2024 Nov 8. doi: 10.1038/s41580-024-00789-x. Online ahead of print. Nat Rev Mol Cell Biol. 2024. PMID: 39516712 Review.
-
Pharmacological targeting of the cancer epigenome.Nat Cancer. 2024 Jun;5(6):844-865. doi: 10.1038/s43018-024-00777-2. Epub 2024 Jun 27. Nat Cancer. 2024. PMID: 38937652 Review.
-
Identification of molecular subtypes based on liquid-liquid phase separation and cross-talk with immunological phenotype in bladder cancer.Front Immunol. 2022 Nov 28;13:1059568. doi: 10.3389/fimmu.2022.1059568. eCollection 2022. Front Immunol. 2022. PMID: 36518754 Free PMC article.
-
Localization of the Drosophila pioneer factor GAF to subnuclear foci is driven by DNA binding and required to silence satellite repeat expression.Dev Cell. 2023 Sep 11;58(17):1610-1624.e8. doi: 10.1016/j.devcel.2023.06.010. Epub 2023 Jul 20. Dev Cell. 2023. PMID: 37478844 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
